Physiological and pathological phosphorylation of tau by Cdk5 - Wikidata - awgldk - TriplyDB

Physiological and pathological phosphorylation of tau by Cdk5

Physiological and pathological phosphorylation of tau by Cdk5

http://www.wikidata.org/entity/Q26860395

about

Current Research Therapeutic Strategies for Alzheimer's Disease Treatment Alzheimer's Disease: Mechanism and Approach to Cell Therapy Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells.Phosphorylation of a splice variant of collapsin response mediator protein 2 in the nucleus of tumour cells links cyclin dependent kinase-5 to oncogenesis.Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies Administration of NaHS Attenuates Footshock-Induced Pathologies and Emotional and Cognitive Dysfunction in Triple Transgenic Alzheimer's Mice.Tau secretion is correlated to an increase of Golgi dynamics.Evaluating Alzheimer's Disease Progression by Modeling Crosstalk Network Disruption An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.Thamnolia vermicularis extract improves learning ability in APP/PS1 transgenic mice by ameliorating both Aβ and Tau pathologies.The neurotoxicity of amyloid β-protein oligomers is reversible in a primary neuron model.Shaping of interphase chromosomes by the microtubule network.The Role of Cdk5 in Alzheimer's Disease.Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies.Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration.Roles of O-GlcNAcylation on amyloid-β precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer's disease.CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation.Therapeutic Strategies for Restoring Tau Homeostasis.Cdk5 links with DNA damage response and cancer.Developmental exposure to lead (Pb) alters the expression of the human tau gene and its products in a transgenic animal model.Comparative analysis of autophagy and tauopathy related markers in cerebral ischemia and Alzheimer's disease animal models.Amyloid β1-42 (Aβ1-42) Induces the CDK2-Mediated Phosphorylation of Tau through the Activation of the mTORC1 Signaling Pathway While Promoting Neuronal Cell Death.Quantitative and combinatory determination of in situ phosphorylation of tau and its FTDP-17 mutants.The effect of Scutellaria baicalensis stem-leaf flavonoids on spatial learning and memory in chronic cerebral ischemia-induced vascular dementia of rats.Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.Inhibition of cyclin-dependent kinase 5 affects early neuroinflammatory signalling in murine model of amyloid beta toxicity.Importance of tau in cognitive decline as revealed by developmental exposure to lead.N-acetyl-L-tryptophan, a substance-P receptor antagonist attenuates aluminum-induced spatial memory deficit in rats.Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.Metal Ion Effects on Aβ and Tau Aggregation.Cdk5 Contributes to Huntington's Disease Learning and Memory Deficits via Modulation of Brain Region-Specific Substrates.Small-molecule PET Tracers for Imaging Proteinopathies.LX2343 alleviates cognitive impairments in AD model rats by inhibiting oxidative stress-induced neuronal apoptosis and tauopathy.Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.A role for tau in learning, memory and synaptic plasticity.Phospho-Tau Bar Code: Analysis of Phosphoisotypes of Tau and Its Application to Tauopathy.Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.U1 snRNP Alteration and Neuronal Cell Cycle Reentry in Alzheimer Disease.Generation of phospho-ubiquitin variants by orthogonal translation reveals codon skipping.

P2860

Q26765530-21651548-4AF0-4885-AF54-F810A0E5749E Q26778149-B0494F49-7B18-435B-909F-46AE9EF0AA24 Q28082139-774579E2-6370-41A0-AACD-9FDF86683705 Q34673431-A08E0CC1-6D2A-4244-8BD9-CCE1A05F7E2E Q35837176-392BF06A-46B5-49FE-B216-6F7897EEB25B Q35854093-6C949F16-0AFA-4D05-BBA8-3E737DB043E3 Q36316228-6C8F1DD8-AF36-4BE7-8CDE-EAC060897EFF Q36383795-24CFB69A-D685-41C0-9ED9-5BA942343872 Q36477601-1A96F80C-E14C-4D0F-A8B9-4E1D05866B17 Q36560502-6981E9E7-BC88-4414-96D2-41DA15026F30 Q37571958-404E5FB6-BDA0-4CAC-83FE-C5E28E3E0809 Q37615463-CAF04E7F-F04F-41D6-ABA7-5CE58439B8BE Q38514865-14541BD2-415B-4013-BAE0-EF9F2B94B76F Q38557958-9AE726C7-6EDE-480D-B6E1-576DD2FD6640 Q38625515-A529F055-2592-4ECA-9C08-90E527D9B83C Q38732547-96813762-F0EB-4A51-A20D-4F58788587F6 Q38808280-E10D968E-AC2B-4868-BB8F-01172F45664F Q38828117-5DFC3AE2-2288-42A5-95A7-7959642F251C Q39118898-117BD7E0-86C3-4667-AC1D-8426A2538012 Q39176295-D12AAFFD-47DE-46E0-9299-B823C719D8A7 Q39200340-066ABF83-1187-46B2-A11F-41798948906F Q40825269-FBA50A4C-22EB-418B-BA90-5838B82D263D Q41097358-FED5ED17-4A4F-4E29-895E-FA6F5648D746 Q41117848-435CA36D-D663-4FA7-95ED-8AE5298802A2 Q41884186-4EA27023-55EB-416F-9F11-F40BFD40521F Q47110701-B193599A-BC72-439A-8627-34473D4E4AD6 Q47128001-03C5E249-8685-491E-9C26-322327CB285C Q47332991-54558BEF-E4F6-4EB6-B776-72E24288959D Q47777443-E0F12103-1BDC-4E68-AF33-5BF6784C32A5 Q47799595-EC6CD04A-E246-449B-A3F5-CE99F91334E4 Q47883269-75C93B75-983A-4A45-9D15-438EDC71AB86 Q47890221-77719407-0074-447D-8E63-3D3DF4E5B4FF Q47926474-C5BFB337-D09E-4B74-99E1-B24BAE2F43F8 Q47993126-CBD42D5D-A877-40A0-86A5-71577AEBFF6E Q48444859-E2081503-F16F-4EDE-BB2D-CBB912B37C3B Q49913378-C0150D1F-B652-4517-919D-5EF08F0C0AD6 Q50202727-02684C5F-04BA-4CE2-B3A8-C9F97AC61E69 Q50520724-2F81FD30-73F7-4D26-9873-A010F12FAF38 Q52328598-9848E5E8-C4BB-434A-B996-43F489E3E6C5 Q54319384-BA8706EA-D734-4CDB-B9EC-B9F2174C7ED7

P2860

Physiological and pathological phosphorylation of tau by Cdk5

http://www.wikidata.org/entity/Q26860395

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Physiological and pathological phosphorylation of tau by Cdk5

@ast

Physiological and pathological phosphorylation of tau by Cdk5

@en

Physiological and pathological phosphorylation of tau by Cdk5

@nl

type

label

Physiological and pathological phosphorylation of tau by Cdk5

@ast

Physiological and pathological phosphorylation of tau by Cdk5

@en

Physiological and pathological phosphorylation of tau by Cdk5

@nl

prefLabel

Physiological and pathological phosphorylation of tau by Cdk5

@ast

Physiological and pathological phosphorylation of tau by Cdk5

@en

Physiological and pathological phosphorylation of tau by Cdk5

@nl

P1433

Q26860395-15D9EFB3-7C40-4CA5-A4C6-1DC047C4595A

P1476

Q26860395-F0A7EF9D-A51B-43BD-85B1-2FDB56BBB4D2

P2093

Q26860395-21D911FA-E2DC-494D-99AF-12DEFE4CC0D4

Q26860395-3F7B28C5-8362-4776-8BF0-A31BDA479774

Q26860395-89A3336E-9B5D-4286-B281-2BD51079DD44

P2860

Q26860395-0027241D-C0DE-4BC3-BDD1-82B8958AEAE6

Q26860395-01643597-CB98-4A6D-B196-A08E18BD427D

Q26860395-03DE4583-9491-44BD-95C5-D654841C53EF

Q26860395-11757294-F4B0-44B1-B10E-318A182FCD8E

Q26860395-122746E9-DFD9-4651-BBFF-0B207E3166C9

Q26860395-12569CB1-01E2-468E-B873-ED5A48AF8400

Q26860395-12DD4935-DDCF-47B0-B3A6-12FEC790BE2A

Q26860395-138086E1-FF2C-4756-8441-9EB27C4270E5

Q26860395-15CD7683-C63C-4EC8-94C0-12F32D936859

Q26860395-17CF43B2-CD54-420F-B3EF-D500A38A46F9

P304

Q26860395-5CFA3788-C903-40D6-BE65-9BFDA4EF06E6

P31

Q26860395-35CE8106-AE78-49D6-8EE9-9B3DB97525E9

P3181

Q26860395-4775FDC4-7211-4D5A-9520-02AD2619C9D5

P356

Q26860395-FB54B022-3D23-459D-8196-03B63D5666A9

P407

Q26860395-B52110D0-AE5D-4D1E-BF78-09749B648A51

P478

Q26860395-AAA1BEA6-B938-4926-98CE-B84EAFC4BB6A

P577

Q26860395-DB0D6D90-F326-4334-8A93-694B34F80686

P5875

Q26860395-113756BF-2480-4926-B229-ED0B6CFE4A01

P698

Q26860395-552BC784-DA0B-475C-BF47-D82E7A6F18D3

P921

Q26860395-2A6FF0CB-1A61-47FC-A2E5-02160DA65F6F

P932

Q26860395-C704DA14-CA49-4D2F-8286-32A3F20657EA

P3181

P356

FNMOL.2014.00065

P1433

Frontiers in molecular neuroscience

P1476

Physiological and pathological phosphorylation of tau by Cdk5

@en

P2093

Koichi Ishiguro

http://www.w3.org/2001/XMLSchema#string

Shin-ichi Hisanaga

http://www.w3.org/2001/XMLSchema#string

Taeko Kimura

http://www.w3.org/2001/XMLSchema#string

P2860

Protein phosphatase 2A dysfunction in Alzheimer's disease

The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein

Tau pathology in Alzheimer disease and other tauopathies

Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain

A family of human cdc2-related protein kinases

An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator

p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5

Silencing of CDK5 reduces neurofibrillary tangles in transgenic alzheimer's mice

Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease

The MAP2/Tau family of microtubule-associated proteins

P304

65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3472236

http://www.w3.org/2001/XMLSchema#string

P356

10.3389/FNMOL.2014.00065

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264388965

http://www.w3.org/2001/XMLSchema#string

P698

25076872

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

4097945

http://www.w3.org/2001/XMLSchema#string